These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23292796)

  • 1. High-throughput screening of small molecules identifies hepcidin antagonists.
    Fung E; Sugianto P; Hsu J; Damoiseaux R; Ganz T; Nemeth E
    Mol Pharmacol; 2013 Mar; 83(3):681-90. PubMed ID: 23292796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination.
    Qiao B; Sugianto P; Fung E; Del-Castillo-Rueda A; Moran-Jimenez MJ; Ganz T; Nemeth E
    Cell Metab; 2012 Jun; 15(6):918-24. PubMed ID: 22682227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepcidin and disorders of iron metabolism.
    Ganz T; Nemeth E
    Annu Rev Med; 2011; 62():347-60. PubMed ID: 20887198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin-ferroportin axis in health and disease.
    Ginzburg YZ
    Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular basis of iron overload disorders and iron-linked anemias.
    Kaplan J; Ward DM; De Domenico I
    Int J Hematol; 2011 Jan; 93(1):14-20. PubMed ID: 21210258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin.
    Kono S; Yoshida K; Tomosugi N; Terada T; Hamaya Y; Kanaoka S; Miyajima H
    Biochim Biophys Acta; 2010 Nov; 1802(11):968-75. PubMed ID: 20655381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.
    Aschemeyer S; Qiao B; Stefanova D; Valore EV; Sek AC; Ruwe TA; Vieth KR; Jung G; Casu C; Rivella S; Jormakka M; Mackenzie B; Ganz T; Nemeth E
    Blood; 2018 Feb; 131(8):899-910. PubMed ID: 29237594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of hepcidin-resistant hereditary hemochromatosis.
    Fernandes A; Preza GC; Phung Y; De Domenico I; Kaplan J; Ganz T; Nemeth E
    Blood; 2009 Jul; 114(2):437-43. PubMed ID: 19383972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2.
    De Domenico I; Lo E; Ward DM; Kaplan J
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3800-5. PubMed ID: 19234114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepcidin targets ferroportin for degradation in hepatocytes.
    Ramey G; Deschemin JC; Durel B; Canonne-Hergaux F; Nicolas G; Vaulont S
    Haematologica; 2010 Mar; 95(3):501-4. PubMed ID: 19773263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation.
    Wallace DF; McDonald CJ; Ostini L; Iser D; Tuckfield A; Subramaniam VN
    Am J Hematol; 2017 Oct; 92(10):1052-1061. PubMed ID: 28681497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia.
    Manolova V; Nyffenegger N; Flace A; Altermatt P; Varol A; Doucerain C; Sundstrom H; Dürrenberger F
    J Clin Invest; 2019 Dec; 130(1):491-506. PubMed ID: 31638596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study.
    Nemeth E; Preza GC; Jung CL; Kaplan J; Waring AJ; Ganz T
    Blood; 2006 Jan; 107(1):328-33. PubMed ID: 16141345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin induces HIV-1 transcription inhibited by ferroportin.
    Xu M; Kashanchi F; Foster A; Rotimi J; Turner W; Gordeuk VR; Nekhai S
    Retrovirology; 2010 Dec; 7():104. PubMed ID: 21126372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin and ferroportin: the new players in iron metabolism.
    De Domenico I; Ward DM; Kaplan J
    Semin Liver Dis; 2011 Aug; 31(3):272-9. PubMed ID: 21901657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload.
    Preza GC; Ruchala P; Pinon R; Ramos E; Qiao B; Peralta MA; Sharma S; Waring A; Ganz T; Nemeth E
    J Clin Invest; 2011 Dec; 121(12):4880-8. PubMed ID: 22045566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.
    Nemeth E; Tuttle MS; Powelson J; Vaughn MB; Donovan A; Ward DM; Ganz T; Kaplan J
    Science; 2004 Dec; 306(5704):2090-3. PubMed ID: 15514116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin and iron homeostasis.
    Ganz T; Nemeth E
    Biochim Biophys Acta; 2012 Sep; 1823(9):1434-43. PubMed ID: 22306005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepcidin-binding site on ferroportin is evolutionarily conserved.
    De Domenico I; Nemeth E; Nelson JM; Phillips JD; Ajioka RS; Kay MS; Kushner JP; Ganz T; Ward DM; Kaplan J
    Cell Metab; 2008 Aug; 8(2):146-56. PubMed ID: 18680715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders.
    Ganz T; Nemeth E
    Hematology Am Soc Hematol Educ Program; 2011; 2011():538-42. PubMed ID: 22160086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.